A. Lipton
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 11
- Bone health and treatments 4
- HER2/EGFR in Cancer Research 4
- Pancreatic and Hepatic Oncology Research 2
-
- Breast Cancer Treatment Studies 3
- Protease and Inhibitor Mechanisms 1
- Co-authors
- Mark Daniel Pegram (1 shared paper)Dennis J. Slamon (1 shared paper)Debu Tripathy (1 shared paper)Sharon A. Baughman (1 shared paper)John A. Glaspy (1 shared paper)José Baselga (1 shared paper)Deborah L. Baly (1 shared paper)Daniel F. Hayes (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (3 papers)Cancer (1 paper)European Journal of Cancer Supplements (1 paper)American Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
A. Lipton
16 papers receiving 1.9k citations
A. Lipton's Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 1.2k
- Cancer Research 357
- Pharmacology 73
- Genetics 148
- Pulmonary and Respiratory Medicine 157
Countries citing papers authored by A. Lipton
This map shows the geographic impact of A. Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lipton more than expected).
Fields of papers citing papers by A. Lipton
This network shows the impact of papers produced by A. Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lipton. The network helps show where A. Lipton may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Lipton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. Hit paper breakdown → | 1998 | 912 |
| 2 | 1998 | 498 | |
| 3 | 1995 | 264 | |
| 4 | 2003 | 108 | |
| 5 | Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination. | 1977 | 78 |
| 6 | The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis. | 1990 | 63 |
| 7 | 1985 | 52 | |
| 8 | 1991 | 48 | |
| 9 | 2014 | 15 | |
| 10 | 1999 | 14 | |
| 11 | 1977 | 10 | |
| 12 | 2004 | 2 | |
| 13 | 1996 | 1 | |
| 14 | 2001 | 1 | |
| 15 | 2002 | 1 | |
| 16 | 2011 | 1 |
About A. Lipton
A. Lipton is a scholar working on Oncology, Cancer Research, Pharmacology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Inflammatory mediators and NSAID effects (1 paper), Protease and Inhibitor Mechanisms (1 paper), Hormonal Regulation and Hypertension (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (357 citations), Pharmacology (73 citations), Genetics (148 citations) and Pulmonary and Respiratory Medicine (157 citations). A. Lipton has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Mark Daniel Pegram, Dennis J. Slamon, Debu Tripathy, Sharon A. Baughman, John A. Glaspy, José Baselga, Deborah L. Baly, Daniel F. Hayes, Harold A. Harvey and Kim Leitzel. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancer, European Journal of Cancer Supplements and American Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.